News

So-Young International Inc. Posts Mixed Results in Q1 2025

So-Young International Inc. Posts Mixed Results in Q1 2025

So-Young Reports First Quarter 2025 Financial Outcomes

So-Young International Inc. (NASDAQ: SY) has revealed its unaudited financial results for the first quarter of 2025, highlighting pivotal data that paints a clear picture of the company’s ongoing growth and operational challenges in the aesthetic treatment sector.

Key Financial Highlights for Q1 2025

Total revenues recorded were RMB297.3 million (approximately US$41.0 million), reflecting a modest decline from RMB318.3 million compared to the same quarter in 2024. This decline, however, remained within the previously anticipated guidance range.

  • Net loss attributable to So-Young was RMB33.1 million (around US$4.6 million), a notable increase from the net loss of RMB21.2 million experienced in Q1 2024.
  • Non-GAAP net loss attributable to So-Young stood at RMB31.5 million (around US$4.3 million), in stark contrast to a non-GAAP net income of RMB4.1 million from the same quarter last year.

Operational Insights for Q1 2025

The total value of medical aesthetic treatment transactions facilitated through So-Young's platform was RMB303.2 million, down from RMB367.1 million in the previous year’s comparable quarter. Furthermore, the surge in verified paid visits surpassed 45,500, up from approximately 4,600, while verified paid aesthetic treatments surpassed 92,900, a drastic increase from about 8,500 in Q1 2024.

Growth in Active Users and New Centers

As of March 31, 2025, active users on So-Young’s platform increased significantly to over 75,700 compared to around 8,000 from the previous year. Additionally, there were 23 operational aesthetic centers across various major cities, with 18 centers generating positive monthly cash flow.

Financial Results Breakdown for Q1 2025

For the quarter, the breakdown of revenues exhibited strong variances across different service categories:

  • Information and reservation services generated RMB142.9 million (approximately US$19.7 million), down 34.1% from the previous year.
  • Revenues from aesthetic treatment services soared to RMB98.8 million (around US$13.6 million), marking a dramatic increase of 551.4% from RMB15.2 million in Q1 2024.
  • Sales of medical products and maintenance services decreased to RMB55.6 million (approximately US$7.7 million), a decline of 35.7% year-over-year.

Management Commentary

Xing Jin, Co-Founder and CEO of So-Young, emphasized the significant momentum within their branded aesthetic centers, indicating robust growth in revenues. He stated, "The strategies we are employing are effectively addressing unmet market demands and generating synergies across our business lines. Our recent integration with Wuhan Miracle Laser has bolstered our product pipeline and improved operational efficiency. We aim to enhance our market presence through an increase in aesthetic centers to provide reliable and high-quality medical aesthetic solutions."

Hui Zhao, CFO of So-Young, further emphasized the emergence of the aesthetic center business as a new growth factor, even though the current revenues reflect ongoing investments aimed at supporting sustainable future growth.

Outlook and Market Predictions

Looking ahead, So-Young anticipates aesthetic treatment service revenues to range between RMB120 million (around US$16.5 million) and RMB140 million (approximately US$19.3 million) for the second quarter of 2025. This projection suggests an impressive growth of between 337.3% to 410.1% when comparing to Q2 2024.

Frequently Asked Questions

What were the total revenues for So-Young in Q1 2025?

The total revenues for So-Young in Q1 2025 were RMB297.3 million, approximately US$41.0 million.

How did the net loss change compared to last year?

The net loss increased to RMB33.1 million compared to RMB21.2 million in the first quarter of 2024.

What operational highlights were noted for Q1 2025?

The number of verified paid visits was over 45,500, and verified paid aesthetic treatments surpassed 92,900.

What is the anticipated revenue range for the next quarter?

So-Young expects revenues from aesthetic treatment services to be between RMB120 million and RMB140 million for the second quarter of 2025.

Who are the key executives at So-Young?

Key executives include Xing Jin as the CEO and Hui Zhao as the CFO, who both focus on strategies for growth and operational efficiency within the company.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 76

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 92

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 88

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Mynd.ai Alters ADS Ratio Affecting Share Dynamics

Updated Category News Views 82

Analyzing Mynd.ai's ADS Ratio Tweak When Mynd.ai decides to shake things up with the American Depositary Shares (ADS) ratio, it's like they're throwing a curveball straight at Wall Street. Listen up, this isn't just a deck shuffle—it's a fundamental tweak that could play a big role in the stock’s perceived value. Starting December 7, 2027, one ADS will leap from...

Continue Reading
James Hardie Joins S&P MidCap 400; Roku Acquired

Updated Category News Views 80

A Shift in the MidCap 400: What's Up? Well, wouldn’t you know it, James Hardie Industries is making waves as it steps into the S&P MidCap 400. This move happens because Fox Corp. has nabbed Roku in a deal worthy of some popcorn. Come November 11, when the trading floor wakes up, James Hardie will be in and Roku will be out. Pretty neat switcheroo if you ask me. Inside...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 100

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 204

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Nemazee Fellowship Advances Clemency and Justice Reform

Updated Category News Views 96

Nemazee Fellowship: A Catalyst for Change You're probably wondering what's really happening when a couple like Hassan and Nazie Nemazee put their name on a legal fellowship. Skipping the melodrama, it's all about making a dent in the criminal justice system. These two aren't just slapping their name on a plaque—they're throwing real support behind actions that matter....

Continue Reading
Havertys Dividend: A Steady Payout Tradition Continues

Updated Category News Views 163

Another Year, Another Dividend for Havertys Man, talk about a company with a rock-solid habit. Havertys Furniture Companies (NYSE: HVT) just announced its latest cash dividend, cementing a tradition that's been rolling since 1935. They're dropping $0.33 per share on the common stock and $0.31 on the Class A common stock. It's set to hit investors' pockets by December 9,...

Continue Reading
IRTC Faces Investigation: Shares Plunge Amid Uncertainty

Updated Category News Views 63

Securities Trouble on the Horizon: IRTC Takes a Hit Wake up and adjust your seat, folks—iRhythm Technologies (NASDAQ:IRTC) is in the spotlight, and it ain't pretty. Shares nosedived over 30% in a single morning, stirring up quite the murky waters for shareholders. The trigger? A less-than-stellar third-quarter report. The Numbers Don't Lie—Or Do They? Management...

Continue Reading

Top 5 Most Recently Viewed Articles

Apertura Gene Therapy Collaborates on Prion Disease Treatment

Updated Category News Views 123

Apertura Gene Therapy Teams Up with Broad Institute Apertura Gene Therapy, a leading biotechnology firm committed to pioneering solutions in gene therapy, is collaborating with the Broad Institute, which is renowned for its groundbreaking research initiatives. The project aims to advance the development of a novel gene therapy targeting prion disease using an engineered...

Continue Reading
Bausch & Lomb Exceeds Expectations with Strong Q3 Growth

Updated Category News Views 67

Bausch & Lomb Achieves Impressive Third Quarter Results Bausch & Lomb Corp. (NYSE:BLCO) has recently captured attention in the financial markets after delivering strong third-quarter results for 2024. H.C. Wainwright, a prominent investment firm, revised the stock price target upward to $23.00 from the previous $22.00 while maintaining a Buy rating on the stock. This...

Continue Reading
Experience Winter Delights with BIGGBY® COFFEE's TWIX® Treats

Updated Category News Views 141

Discover the Seasonal Magic of BIGGBY® COFFEE The new limited-time winter offerings from BIGGBY® COFFEE are designed to delight cocoa and coffee lovers alike. This season, fans can indulge in a unique Salted Caramel lineup inspired by TWIX® candy. These festive beverages are available from early January through late February, providing a decadent way to enjoy the...

Continue Reading
Borr Drilling Limited's New Offering: What Investors Should Know

Updated Category News Views 229

Borr Drilling Limited Plans Significant Share Offering Borr Drilling Limited (NYSE: BORR) has recently announced plans to conduct a public offering of its common shares, intending to raise approximately $85 million in gross proceeds. The company aims to offer around 21 million shares in this equity initiative, reflecting its commitment to continued growth and investment...

Continue Reading